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Abstract: Recent work has shown that chemical release during
the fundamental cellular process of exocytosis in model cell
lines is not all-or-none. We tested this theory for vesicular
release from single pancreatic beta cells. The vesicles in these
cells release insulin, but also serotonin, which is detectible with
amperometric methods. Traditionally, it is assumed that
exocytosis in beta cells is all-or-none. Here, we use a multi-
disciplinary approach involving nanoscale amperometric
chemical methods to explore the chemical nature of insulin
exocytosis. We amperometrically quantified the number of
serotonin molecules stored inside of individual nanoscale
vesicles (39317 1611) in the cell cytoplasm before exocytosis
and the number of serotonin molecules released from single
cells (13310 1127) for each stimulated exocytosis event.
Thus, beta cells release only one-third of their granule content,
clearly supporting partial release in this system. We discuss
these observations in the context of type-2 diabetes.
Insulin is a metabolic hormone produced and released by the
pancreatic islets. Each islet contains several different endo-
crine cell types with different responsibilities in the regulation
of systemic metabolism. Among these are the beta cells which
secrete insulin that lowers blood glucose levels.[1]
Insulin is stored as a hexamer complex with Zn ions
(INS6Zn2) inside secretory nano granules or vesicles (50–
300 nm diameter).[2] Generally, when glucose levels increase,
beta cells start to secrete insulin by the process of exocytosis
to decrease glucose levels. During rapid exocytosis (< 50 ms),
the vesicles dock to and fuse with the plasma membrane. This
involves the formation of a fusion pore through which some
or all of their cargo is released into the extracellular space. In
the extracellular space, the insulin complex dissociates into
insulin monomers, which acts on the target organs to promote
glucose storage. Inadequate exocytotic release of insulin leads
to type-2 diabetes.[3] Hence, a detailed understanding of
exocytosis in beta cells may help to establish the underlying
molecular and cellular causes of the disease.
Until recently, exocytosis in general was thought to be
principally an all-or-none event. More recently kiss- and- run
and partial release modes have also been defined.[4] Partial
release has been shown to be the predominant mode of
release in PC12 and adrenal chromaffin cells[4b,c,5] as well as in
the neurons of Drosophila larvae.[5e] Subsequent work has
shown that the exocytotic process can be regulated at the level
of a single release event by varying the fraction released.[5a,b,6]
The partial release concept has been supported with TIRF
and super-resolution STED microscopy at adrenal chromaffin
cells.[7]
In this paper, we use electrochemical methods to inves-
tigate whether exocytosis in beta cells is all or partial, a critical
issue in determining the amount of hormone released. Many
techniques have been used to study exocytosis at beta cells
including immunosorbent assays, radioimmunoassays, fluo-
rescence microscopy, chemiluminescence, and electron mi-
croscopy.[8] These methods have low temporal resolution, and
they do not address the question whether the release process
is all-or-none or partial. To fill this gap, amperometry with
micro/nanoelectrodes is currently the only method with both
high temporal resolution (ms) and the quantitative ability
to count target molecules in single vesicles or during
exocytotic release.[9] Amperometry at PC12 cells has recently
been used to examine a repeated stimulation paradigm to
observe plastic changes in the fraction released during
exocytosis.[6f]
For intracellular analysis, we have used amperometry at
a nanotip electrode to carry out intracellular vesicle impact
electrochemical cytometry (IVIEC) to detect vesicle content
in situ.[5] The IVIEC and SCA approaches are shown in
Figure 1. In both cases, we chose to measure serotonin (5-
hydroxytryptamine(5-HT)),[10] as it was difficult to electro-
analyze insulin and 5-HT is loaded in beta cell vesicles. 5-HT
is easily oxidized and detected at CFEs and as it is co-released
with insulin is an excellent surrogate of insulin during beta
cells exocytosis.[11]
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The vesicle cargo of beta cells generally includes the
insulin hexamer complex, free Zn2+ ions, C-peptide, ATP, 5-
HT and a small amount of gamma-aminobutyric acid
(GABA).[1a] The risk of any interference in amperometric
measurement is therefore negligible. Generally, trace
amounts of 5-HT are stored by pancreatic beta cells, but
levels are low and basal levels cannot be detected by
amperometry.[11d] To solve this, beta cells were preloaded by
5-HT via incubation and selective uptake into secretory
vesicles has been demonstrated.[12,11d]
Serotonin that is secreted during exocytosis or in single
vesicles can be quantified by oxidation (+ 700 mV vs. Ag/
AgCl) at the surface of a disk carbon fibre electrode (CFE)
(Figure 1). Single-cell amperometry (SCA) is used to quantify
exocytosis. Here we quantitatively measure all the released
catecholamine for vesicles under the electrode and this has
been verified by comparing electrodes of different sizes.[6f]
Additionally, we only use events with rapid rise times (25% to
75% < 0.5 ms) to avoid measuring release from outside the
electrode.
Recent work has shown that chemical release during the
fundamental cellular process of exocytosis in model cell lines
is not all or none. We tested this theory for vesicular release
from single pancreatic beta cells. The vesicles in these cells
release insulin, but also serotonin, which is detectible with
amperometric methods. Traditionally, it is assumed that
exocytosis in beta cells is all-or-none. Here we use a multi-
disciplinary approach involving nanoscale amperometric
chemical methods to explore the chemical nature of insulin
exocytosis. We amperometrically quantified the number of
serotonin molecules stored inside of individual nanoscale
vesicles (39 317 1611) in the cell cytoplasm before exocy-
tosis and the number of serotonin molecules released from
single cells (13 310 1127) for each stimulated exocytosis
event. Thus, beta cells release only one-third of their granule
content, clearly supporting partial release in this system. We
discuss these observations in the context of type-2 diabetes.
To measure 5-HT stored inside vesicles, a nanoscale tip
CFE is inserted into the cell (Figure 1) is used where the
vesicles adsorb on the electrode surface, rupture due to
electroporation, and their contents are oxidized. This
approach can be used to quantify the total electroactive
content of each vesicle.[13, 5a]
For amperometric experiments, primary mouse pancreatic
beta cells (cell isolation is described in detail in the supporting
information (SI)) were incubated in tissue culture RPMI 1640
media containing 0.5 mM 5-HT and 1 mM 5-hydroxytrypto-
phan (serotonin precursor) at 378 C, 5% CO2 for 16–18 h. The
5-hydroxytryptophan is enzymatically converted to 5-HT
after it enters the cytoplasm.[11d, e] Just before amperometric
measurements, the extracellular medium was changed to
Krebs buffer solution (SI). Measurements were performed at
37 8C. Nano-tip CFEs (see SI for fabrication method and
sizes) were used to quantify the amount of stored 5-HT in
intracellular vesicles.[6] The nano-tip electrode was placed on
the top of a single unstimulated cell and pushed gently into it
with a micromanipulator while applying a voltage to the
electrode and recording current (Figure 1). In IVIEC, cyto-
plasmic vesicles adsorb on the electrode surface and open by
electroporation.[5, 6] Bursting vesicles expose their contents,
allowing 5-HT to be electrochemically detected and quanti-
fied (Figure 2A,B).
To quantify released 5-HT from single cell during
exocytosis, a disk CFE (fabrication and size described in SI)
was positioned gently over the top of a single beta cell
(Figure 1). Then, we used a nanopipette (Figure 2C) to locally
elevate the extracellular K+ concentration. As the beta cell
membrane potential is principally determined by the K +
permeability this rapidly depolarizes the beta cell, thereby
activating voltage-gated Ca2+ channels,[3] initiating exocytosis
events recorded as amperometric current spikes (Fig-
ure 2C,D).
For both amperometric measurements, the number of 5-
HT molecules can be quantified with Faradays law N = Q/
nF,[6] where Q is the charge from the time integral ampero-
metric spikes, N the number of molecules released from single
vesicle, F is the Faraday constant, and n is the number of
electrons exchanged in the oxidation reaction (n = 2 for 5-
HT). We used SCA and IVIEC to compare the amount of 5-
HT released via exocytosis to the total vesicular 5-HT content
and the results are presented in a normalized frequency
histogram (Figure 1S, Supporting Information). A large range
of vesicles with different content ranging up to  400 000 5-
HT molecules was observed with IVIEC (Figure 1S-A), while
up to  120 000 molecules were released via exocytosis.
Interestingly, the distributions observed for exocytotic release
versus vesicular content suggest that the fraction of 5-HT
molecules released during exocytosis differs for individual
vesicles.
Figure 1. Schematic illustration of amperometry measurements of
exocytosis by disk carbon fibre electrode (DCFE) and vesicle contents
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The large range of distributions for 5-HT molecules stored
in vesicles might result from factors such as different
preloading rates in individual vesicles, the vesicle size, and
variable efficiencies between cells in the production of 5-HT
from the 5-hydroxytryptophan precursor. IVIEC measure-
ments (Figure 1S-A), show a smaller number of events with
higher 5-HT content. Consequently, we examined the data by
dividing it into three subgroups. We then used the mean of the
medians (to minimize the influence of the cell-to-cell and
vesicle-to-vesicle variation) of the amount of 5-HT to
compare and calculate the fraction released via exocytosis
(Figure 1S).
The fraction released for 5-HT in the different ranges was
estimated by using the median of each range separately
(Figure 1S). The results show that the fraction released ranges
from 20 to 34 %, and fractional release from vesicles with
higher molecular content is decreased. Although there is
a wide range of vesicular content from IVIEC, most vesicles
(approx. 60–70 %) contain less than 140 000 molecules. We
therefore focused on the range in which the majority of events
are located to decrease deviations and possible errors in the
estimation of the fraction of 5-HT molecules released.
A comparison of IVIEC data (choosing the reduced size
range with data points from 0–140000) to the SCA data is
presented in Figure 3. The number of stored 5-HT molecules
was higher (39317 1611 molecules, mean of medians 
SEM, 558 spikes from 51 cells) in comparison to released 5-
HT (13310 1127 molecules, mean of medians  SEM, 1442
spikes from 26 cells). These data show that even when
omitting the larger content vesicles only 34% of the 5-HT
content is released during beta cell exocytosis. Thus, it is
justifiable to conclude that a large portion of full exocytosis
events from pancreatic beta cells undergo a process whereby
only a fraction of the vesicular cargo is released via the fusion
pore. If anything, by excluding the vesicles with the highest
molecular content, we report a lower estimate of the frac-
tional release. These findings echo observations in chromaffin
and PC12 cells, as well as exocytosis from nerve cells in
Drosophila larvae.[4b,c,5e, 6b,d,f]
In summary, we used two sensitive electrochemical
methods, to obtain the fraction of 5-HT (as a proxy for
insulin) released during exocytosis at the single-cell level with
a goal of determining if release from beta cells is partial. The
number of 5-HT molecules released during exocytosis is
 34% of the stored content or lower. We conclude that
partial release must be an important mechanism of exocytosis
from beta cells. If this occurs for a small molecule like 5-HT
that will pass with relative ease through the partially open
fusion pore, then it is likely that that the release of large
molecules (such as the insulin hexamer) will be impeded more
strongly. The same is true if the release is in part hindered by
binding to a protein dense core in the vesicle as the larger
insulin is expected to bind more tightly. This quantitative
finding is highly relevant for the understanding of the causes
of type-2 diabetes, a metabolic disorder resulting from
insufficient insulin release.[3] It is possible that beta cells
physiologically regulate insulin release with exquisite preci-
sion by controlling release at the level of individual exocytosis
events and that this regulation becomes impaired in type-2
Figure 2. A) Representative amperometric trace for intracellular vesicle
impact electrochemical cytometry from 5-HT loaded mouse primary
beta cell (inset: amplified amperometric current spike marked in the
amperometric trace). Optical micrographs showing the experimental
setups for B) IVIEC and C) SCA measurements. D) Representative
amperometric trace for single cell amperometry from 5-HT loaded
mouse primary beta cell. Detection of exocytosis was carried out by
applying 700 mV vs. Ag/AgCl. Cells were stimulated by application of
60 mM K+ stimulating solution. (inset: amplified amperometric cur-
rent spike marked in the amperometric trace).
Figure 3. A) Histograms of released 5-HT of exocytosis by SCA (blue,
cells number = 26) and vesicle content by IVIEC (red, cells
number = 51) from preloaded mouse primary beta cells. B) Mean of
median of number of molecules detected by SCA and IVIEC in the
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diabetes. These data therefore raise the tantalising possibility
that pharmacological intervention can be used to increase the
fraction released during beta cell exocytosis and lead to new
therapies for type-2 diabetes.
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